# Clinical Effects of Metformin on Fertility-sparing Treatment for Early Endometrial Cancer

> **NCT04792749** · PHASE3 · UNKNOWN · sponsor: **Samsung Medical Center** · enrollment: 77 (estimated)

## Conditions studied

- Endometrial Cancer Stage I

## Interventions

- **DRUG:** Metformin

## Key facts

- **NCT ID:** NCT04792749
- **Lead sponsor:** Samsung Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-06-01
- **Primary completion:** 2023-12-31
- **Final completion:** 2024-03-31
- **Target enrollment:** 77 (ESTIMATED)
- **Last updated:** 2023-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04792749

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04792749, "Clinical Effects of Metformin on Fertility-sparing Treatment for Early Endometrial Cancer". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT04792749. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*